Akron Children’s seasonal visitor restriction policy is effective Nov. 4-April 1

Get Care

New Parents

Who We Are

Your Visit

Health Info

I WANT TO…

Akron Children's > For Families & Patients > Research > Pediatric Clinical Studies > Open Clinical Studies

Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed Hodgkin Lymphoma

Full IRB Study Title:
A Randomized Phase III Study of Brentuximab Vedotin (SGN-35) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Adolescents

IRB Study ID: 1038558-1

For complete study information, please view the study on clincaltrials.gov.

Akron Children‘s Anywhere Mobile App

Managing your child‘s health, made easier

Dog Mascot with Akron Children's Anywhere Mobile App

Akron Children‘s Anywhere Mobile App

Managing your child‘s health, made easier

Akron Children‘s Anywhere is designed to be your “go-to app” for managing your child‘s health. It provides tools for finding a primary care doctor or specialist, finding locations and directions, and making everyday health decisions as well as giving you quick, secure access to MyChart and other tools. And when your child needs care, the renowned experts at Akron Children‘s are just one tap away.

Apple App Store Anywhere Mobile App Download Button

Google Play Anywhere Mobile App Download Button

By using this site, you consent to our use of cookies. To learn more, read our privacy policy.